We are pleased to announce that our involvement in WHX Labs Dubai 2026 - the leading international healthcare exhibition hosted at the Dubai World Trade Centre from February 10th to 13th was an overwhelming success. This event gathered healthcare practitioners, industry pioneers, and innovators from across the globe, and we were privileged to showcase CITEST's cutting-edge diagnostic technologies at Booth H3.F39, which welcomed a steady flow of interested attendees over the four-day period.
Our booth featured a curated selection of innovative in-vitro diagnostic (IVD) products. Standout offerings included our rapid diagnostic test lineup, such as the H. pylori Antigen Test, Dengue NS1 & IgG/IgM Combo Test, HBsAg/HCV/HIV/Syphilis Combo Test, SARS-CoV-2/Influenza A+B/RSV Antigen Combo Test, and Multi-Drug Test Panels. Complementing these tests were analytical devices like the Fluorescence Immunoassay Analyzer and Urine Analyzer. Every product generated considerable attention, with numerous visitors commending their dependability, precision, and flexibility in adapting to different clinical and operational settings. On-site demonstrations helped us showcase how our solutions can be smoothly integrated into various diagnostic processes.
WHX Labs Dubai 2026 acted as a crucial platform for tackling modern healthcare challenges, including boosting diagnostic accessibility and efficiency. Our product range struck a chord with participants, demonstrating a common dedication to advancing patient care through technological innovation. Additionally, we held productive discussions with potential partners, exploring opportunities for cooperative pilot projects and localized solutions designed to meet regional healthcare requirements.
In summary, the exhibition offered priceless chances for knowledge sharing, relationship development, and market understanding. We would like to thank everyone who visited our booth and showed interest in CITEST’s mission. Leaving Dubai, we are inspired and equipped with new connections and feedback that will guide our ongoing efforts to shape the future of diagnostics - making high-quality healthcare more attainable, precise, and impactful across the world.
